Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Barriers to Clinical Trial Efficiency and Patient Access: The Heart Failure Collaboratory Industry Survey

Shashank S. Sinha, Mitchell A. Psotka, Mona Fiuzat, Scott D. Barnett, Martina Bruckmann, Javed Butler, Mary M. DeSouza, G. Michael Felker, Scott D. Solomon, Norman Stockbridge, John R. Teerlink, Ellis F. Unger, Christopher M. O’Connor, Marvin A. Konstam
doi: https://doi.org/10.1101/2020.06.24.20124917
Shashank S. Sinha
1Inova Heart and Vascular Institute, Falls Church, Virginia, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitchell A. Psotka
1Inova Heart and Vascular Institute, Falls Church, Virginia, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mona Fiuzat
2Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA
3U.S. Food and Drug Administration, Silver Spring, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott D. Barnett
1Inova Heart and Vascular Institute, Falls Church, Virginia, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martina Bruckmann
4Therapeutic Area Cardiometabolism, Boehringer-Ingelheim International, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javed Butler
5Department of Medicine, University of Mississippi, Jackson, Mississippi, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary M. DeSouza
6Bristol-Meyers Squibb, Princeton, NJ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Michael Felker
2Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott D. Solomon
7Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norman Stockbridge
3U.S. Food and Drug Administration, Silver Spring, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John R. Teerlink
8Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ellis F. Unger
3U.S. Food and Drug Administration, Silver Spring, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher M. O’Connor
1Inova Heart and Vascular Institute, Falls Church, Virginia, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marvin A. Konstam
9CardioVascular Center of Tufts Medical Center, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mkonstam@tuftsmedicalcenter.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Aims Clinical trial inefficiency and lack of patient access to novel therapies have been identified as key barriers to successful heart failure innovation. The Heart Failure Collaboratory (HFC) is a consortium developed to identify and address barriers to bringing drugs and devices to market. The HFC performed an electronic cross-sectional survey of key leaders within industry to collate and interpret a sample of viewpoints on these challenges.

Methods and Results From August to September 2018, self-administered survey data were electronically collected from industry partners. Group comparisons were made via Fisher’s Exact or chi-square test. Respondents most commonly rated the United States Food and Drug Administration (44.2%), Health Canada (39.5%) and European Medicines Agency (32.6%) as efficient. Respondents rated the top 3 areas with the greatest opportunity for regulatory agencies to improve efficiency: ‘improve usefulness of agency feedback’ (48.8%); ‘improved timeliness of agency responses’ (41.9%); and ‘pre-specification of required magnitude of clinical effect’ and ‘limit excessive data requirements’ (32.6%). Respondents rated items of ‘excessive clinical site staff workload’ (55.8%), ‘overly complex case report forms’ (51.2%) and ‘data input errors’ (39.5%) as the top 3 factors influencing data quality. Respondents rated items of ‘onerous prior authorization requirements’ (51.2%), ‘availability of decision-making rationale’ (46.5%) and ‘rationality of access barriers created by payers’ (44.2%) as the top 3 impediments to improving patient access to approved therapies.

Conclusion This broadly distributed survey of industry respondents identified multiple specific barriers to heart failure clinical trial efficiency and patient access, which should help direct efforts toward improvement.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding was obtained for this work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

As this was a survey of industry participants, IRB approval/exemption was not required (as no patient subjects were assessed or harmed during this study).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The primary and corresponding author take full responsibility for primary data collection and analysis.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 29, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Barriers to Clinical Trial Efficiency and Patient Access: The Heart Failure Collaboratory Industry Survey
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Barriers to Clinical Trial Efficiency and Patient Access: The Heart Failure Collaboratory Industry Survey
Shashank S. Sinha, Mitchell A. Psotka, Mona Fiuzat, Scott D. Barnett, Martina Bruckmann, Javed Butler, Mary M. DeSouza, G. Michael Felker, Scott D. Solomon, Norman Stockbridge, John R. Teerlink, Ellis F. Unger, Christopher M. O’Connor, Marvin A. Konstam
medRxiv 2020.06.24.20124917; doi: https://doi.org/10.1101/2020.06.24.20124917
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Barriers to Clinical Trial Efficiency and Patient Access: The Heart Failure Collaboratory Industry Survey
Shashank S. Sinha, Mitchell A. Psotka, Mona Fiuzat, Scott D. Barnett, Martina Bruckmann, Javed Butler, Mary M. DeSouza, G. Michael Felker, Scott D. Solomon, Norman Stockbridge, John R. Teerlink, Ellis F. Unger, Christopher M. O’Connor, Marvin A. Konstam
medRxiv 2020.06.24.20124917; doi: https://doi.org/10.1101/2020.06.24.20124917

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Policy
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (455)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (159)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5296)
  • Forensic Medicine (3)
  • Gastroenterology (198)
  • Genetic and Genomic Medicine (760)
  • Geriatric Medicine (80)
  • Health Economics (214)
  • Health Informatics (702)
  • Health Policy (363)
  • Health Systems and Quality Improvement (224)
  • Hematology (100)
  • HIV/AIDS (165)
  • Infectious Diseases (except HIV/AIDS) (5935)
  • Intensive Care and Critical Care Medicine (367)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (772)
  • Nursing (43)
  • Nutrition (135)
  • Obstetrics and Gynecology (146)
  • Occupational and Environmental Health (234)
  • Oncology (481)
  • Ophthalmology (153)
  • Orthopedics (39)
  • Otolaryngology (97)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (138)
  • Primary Care Research (99)
  • Psychiatry and Clinical Psychology (865)
  • Public and Global Health (2035)
  • Radiology and Imaging (354)
  • Rehabilitation Medicine and Physical Therapy (159)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)